CRISPR-Cas9-mediated exon skipping as a cardioprotective strategy in Duchenne muscular dystrophy

被引：2
作者：
Wilton-Clark, Harry [1 ]
Yokota, Toshifumi [1 ]
机构：
[1] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada
来源：
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT | 2023年 / 30卷
关键词：
D O I：
10.1016/j.omtm.2023.08.013
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：500 / 501
页数：2
相关论文
共 50 条
[41]   Theoretic Applicability of Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy Mutations [J].
Aartsma-Rus, Annemieke ;
Fokkema, Ivo ;
Verschuuren, Jan ;
Ginjaar, Leke ;
van Deutekom, Judith ;
van Ommen, Gert-Jan ;
den Dunnen, Johan T. .
HUMAN MUTATION, 2009, 30 (03) :293-299
[42]   Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy [J].
Yokota, Toshifumi ;
Pistilli, Emidio ;
Duddy, William ;
Nagaraju, Kanneboyina .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (06) :831-842
[43]   Systemic Antisense-Mediated Exon Skipping in Mouse Models for Duchenne Muscular Dystrophy [J].
Aartsma-Rus, Annemieke ;
Heemskerk, Hans ;
De Winter, Christa ;
Van Putten, Maaike ;
Janson, Anneke ;
Verschuuren, Jan ;
Den Dunnen, Johan ;
Van Deutekom, Judith ;
Van Ommen, Gert-Jan .
MOLECULAR THERAPY, 2009, 17 :S166-S166
[44]   U7snRNA-Mediated Exon 17 Skipping in Duchenne Muscular Dystrophy [J].
Gushchina, Liubov V. ;
Dufresne, Gabrielle ;
Saylam, Ezgi ;
Bradley, Adrienne ;
Rohan, Natalie ;
Lowery, Allison ;
Lin, Hui ;
Wein, Nicolas ;
Flanigan, Kevin M. .
MOLECULAR THERAPY, 2024, 32 (04) :701-701
[45]   Beyond clinical trials for antisense-mediated exon skipping for Duchenne muscular dystrophy [J].
Aartsma-Rus, Annemieke .
HUMAN GENE THERAPY, 2014, 25 (11) :A13-A13
[46]   Antisense-mediated exon skipping as a gene correction therapy for Duchenne muscular dystrophy [J].
van Deutekom, J ;
Aartsma-Rus, A ;
Bremmer-Bout, M ;
Janson, A ;
den Dunnen, J ;
van Ommen, GJ .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 :S75-S76
[47]   Optimization of antisense-mediated exon skipping in mouse models for Duchenne muscular dystrophy [J].
Aartsma-Rus, A. ;
Heemskerk, H. A. ;
de Winter, C. L. ;
van Putten, M. ;
De Kimpe, S. ;
van Deutekom, J. C. T. ;
van Ommen, G. J. B. .
NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) :757-757
[48]   Current Outline of Exon Skipping Trials in Duchenne Muscular Dystrophy [J].
Eser, Gokce ;
Topaloglu, Haluk .
GENES, 2022, 13 (07)
[49]   Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy [J].
Kemaladewi, Dwi U. ;
Hoogaars, Willem M. H. ;
van Heiningen, Sandra H. ;
Terlouw, Samuel ;
de Gorter, David J. J. ;
den Dunnen, Johan T. ;
van Ommen, Gert Jan B. ;
Aartsma-Rus, Annemieke ;
ten Dijke, Peter ;
't Hoen, Peter A. C. .
BMC MEDICAL GENOMICS, 2011, 4
[50]   EXON SKIPPING AND DUCHENNE MUSCULAR DYSTROPHY: A CLINICAL TRIAL UPDATE [J].
Wilton, Steve ;
Fletcher, Sue .
JOURNAL OF GENE MEDICINE, 2013, 15 (8-9) :330-330
12345